Our subcutaneous tumor xenografts studies revealed that the enforced expression of ALDH9A1 remarkably restrained the tumor growth in comparisons with the vector group, whereas the knockdown of IQGAP2 reversed the impact of ALDH9A1 overexpression on the tumor growth (Fig. 8A). The gene discussed is IQGAP2; the disease is neoplasm.